Clinical Trial Update: Addition of Lactobacillus to Metronidazole in Treatment of CDAD [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating addition of a Lactobacillus probiotic to metronidazole for Clostridioides difficile infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Pseudomembranous Colitis

Drugs mentioned

• Lactobacillus (lactobacillus)
• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Michael E. DeBakey VA Medical Center | Conditions: Enterocolitis, Pseudomembranous Colitis | Phase 4 | Status: WITHDRAWN